Dentists in Hegins, PA Accepting Medicare
6 Dentists found. Showing 1 - 6
 Dr. John Walter Horn, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 215 Grove Drive, Hegins, PA 17938 Phone: 570-682-3249 |
Dr. Jack Aughenbaugh, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1144 E Main St, Hegins, PA 17938 Phone: 570-682-8143 |
 Aasiya Mohammed Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1144 E Main St, Hegins, PA 17938 Phone: 570-682-8143 |
Dr. Ellen F Boran, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1144 E. Main St., Hegins, PA 17938 Phone: 570-682-8143 Fax: 570-682-8630 |
Farah Jamal, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1144 E Main St, Hegins, PA 17938 Phone: 516-513-9758 |
Dr. Alec Starostik, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1144 E Main St, Hegins, PA 17938 Phone: 570-682-8143 |
News Archive
Rohto launches AFC Medirepair with Signum's compound Arazine in Japan
Signum Biosciences announced that its partner, Rohto Pharmaceutical Co., Ltd., has launched AFC Medirepair® with Signum's compound Arazine™ (n-acetyl-s-farnsylcysteine or AFC) in Japan. Arazine™ is the first compound from Signum's novel anti-inflammatory platform to be commercialized from Signum's pipeline of Signal Transduction Modulators (STMs).
Children with COVID-19 presenting with sudden severe lung disease
Even as the COVID-19 pandemic continues to seek out new victims, puzzling new presentations are further confusing the situation. A new study published online in The Lancet Rheumatology in May 2020 reports a case of severe COVID-19 in a child who rapidly developed acute respiratory distress symptoms without prior respiratory symptoms. This case should alert clinicians to consider this diagnosis in children as well.
College students more likely to talk about sexual health issues after watching TV shows
"What would Samantha and Miranda do?" That's what viewers of the past HBO series Sex and the City may ask themselves when faced with the prospect of uncomfortable discussions about sexual health with partners, friends and doctors.
Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients
Centocor Ortho Biotech Inc. announced today that it has filed a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) requesting the approval of REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.
› Verified 3 days ago